FK228 sensitizes radioresistant small cell lung cancer cells to radiation

BACKGROUND: Concurrent thoracic radiation plus chemotherapy is the mainstay of first-line treatment for limited-stage small cell lung cancer (LS-SCLC). Despite initial high responsiveness to combined chemo- and radiotherapy, SCLC almost invariably relapses and develops resistance within one year, le...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong, Ma, Liying, Bian, Xing, Lv, Yang, Lin, Wenchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905898/
https://www.ncbi.nlm.nih.gov/pubmed/33632300
http://dx.doi.org/10.1186/s13148-021-01025-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905898/
https://www.ncbi.nlm.nih.gov/pubmed/33632300
http://dx.doi.org/10.1186/s13148-021-01025-5

Ejemplares similares